Skip to main content
REVB
NASDAQ Life Sciences

Revelation Biosciences Q3 2026: $9.1M Cash, Going Concern, Nasdaq MVLS Delisting Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.56
Mkt Cap
$2.026M
52W Low
$3.08
52W High
$40.6
52W Position info
16% above low
Off High info
91% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

REVB sits 16% above its 52-week low of $3.08.

Summary

Revelation Biosciences posted a $9.6 million nine-month net loss and held $9.1 million of cash, warned it cannot fund a full year of operations, and flagged that its listed-securities value sits below the $5 million threshold of a new Nasdaq automatic-delisting rule.


Key Events · Earnings and Guidance · REVB

  • Q3 2026 Loss Widens to $9.6M

    Nine-month net loss reached $9.6 million versus $6.4 million a year earlier, with Q3 alone losing $3.3 million as R&D rose to $1.5 million from $0.9 million.

  • Cash Falls to $9.1M, Going Concern

    Cash and equivalents dropped to $9.1 million from $10.7 million at December 31, 2025, and management says the balance will not sustain operations for a year.

  • Nasdaq MVLS Delisting Risk

    Under a new Nasdaq rule, companies whose listed-securities value stays below $5 million for 30 consecutive business days face automatic delisting with no cure period; the company says it is currently below that level.

  • Reverse Split Resets Warrant Strikes

    The October 20, 2026 1-for-7 split cut Class C, D, G, H, I and J warrant exercise prices from $12.46 to $3.29 and raised Class G warrant shares from 489,250 to 1,852,908.


Analysis · REVB · Life Sciences

A fresh capital raise is now on the near-term agenda: the company closed September 30, 2026 with $9.1 million in cash against a $9.6 million nine-month net loss, and management states plainly that this balance will not fund operations for a year. Layered on top is a newly operative Nasdaq rule that automatically delists companies whose listed-securities value stays under $5 million for 30 consecutive business days, with no cure period; the filing says the company is already below that threshold. Even after the 1-for-7 reverse split on October 20, 2026, the equity structure remains heavily overhung — that split reset warrant strikes from $12.46 to $3.29 and ballooned Class G warrant shares to 1,852,908.

How filings like this one have moved

In the 30 days to Nov 5, 2026, 43.4% of the 1274 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.16%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, REVB was trading at $3.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2M. The 52-week trading range was $3.08 to $40.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

REVB - Latest Insights

REVB
Oct 16, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.7622
Real-time Price: $3.56 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $3.56 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Aug 06, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $3.56 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Jul 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9869
Real-time Price: $3.56 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Jun 24, 2026, 4:47 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.03
Real-time Price: $3.56 info
Change: Reverse Stock Split info
Market Cap: $2.026M info